跳至主要内容
临床试验/IRCT201108012106N2
IRCT201108012106N2已完成2 期

Evaluation of effect of folic acid in Buerger`s disease on homo cysteine and clinical status

Applied Physiology Research Center0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • Buerger`s patients referring to Alzahra hospital who have consent of participation to study; history of smoking; onset of disease before 50 year-old; upper limb involvement or phlebitis migrants; obliterative arterial disease below popliteal artery and no risk factor of atherosclerosis except smoking; no history of hypertension, diabetes mellitus, ischemic heart disease, cerebrovascular disease or collagen vascular disease.
  • Exclusion criteria: surgical (sympathectomy or vascular bypass) or medical (Illeoprost or corticosteroid) changes in treatment; starting Aspirin, calcium channel blocker, VitB6 or VitB12 or stop smoking during the study; drug incompliance during the study and not willing to continue the study.

排除标准

  • 未提供

研究者

发起方
Applied Physiology Research Center

相似试验